造血干细胞移植在非霍奇金淋巴瘤综合治疗中的作用

[1]	PHILIP T,GUGLIELMI C,HAGENBEEK A,et al.Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma[J].N Engl J Med,1995,333:1540-1545.
[2]	GISSELBRECHT C,GLASS B,MOUNIER N,et al.Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era[J].J Clin Oncol,2010,28:4184-4190.
[3]	HAIOUN C,MOUNIER N,EMILE J F,et al.Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma[J].Ann Oncol,2009,20:1985-1992.
[4]	MOUNIER N,GISSELBRECHT C,FITOUSSI O,et al.Benefit of rituximab combined with ACVBP(R-ACVBP)over ACVBP in 209 poor-risk BDLC NHL patients treated with up-front consolidative autotransplantation:a GELA phase II trial(LNH 2003-3).American Society of Clinical Oncology[J].J Clin Oncol,2009,27:435-435.
[5]	KHOURI I F,LEE M S,SALIBA R M,et al.Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma[J].J Clin Oncol, 2003,21:4407-4412.
[6]	MARIS M B,SANDMAIER B M,STORER B E,et al.Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphorra[J].Blood,2004,104:3535-3542.
[7]	DECONINCK E,FOUSSARD C,MILPIED N,et al.High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma:a randomized multicenter study by GOELAMS[J].Blood,2005,105:3817-3823.
[8]	SCHOUTEN H C,QIAN W,KVALOY S,et al.High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma:results from the randomized European CUP trial[J].J Clin Oncol,2003,21:3918-3927.
[9]	GOPAL A K,GOOLEY T A,MALONEY D G,et al.High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma:a multivariable cohort analysis[J].Blood,2003,102:2351-2357.
[10]	VAN BESIEN K,LOBERIZA F R,BAJORUNAITE R,et al.Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma[J].Blood,2003,102:3521-3529.
[11]	VIGOUROUX S,GAILLARD F,MOREAU P,et al.High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma[J].Haematologica,2005,90:1580-1582.
[12]	KHOURI I F,SALIBA R M,OKOROJI G J,et al.Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission:the prognostic value of beta2-microglobulin and the tumor score[J].Cancer,2003,98:2630-2635.
[13]	LEFRERE F,DELMER A,LEVY V,et al.Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma:an update of a prospective study[J].Haematologica,2004,89:1275-1276.
[14]	DREGER P,RIEGER M,SEYFARTH B,et al.Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma:effects on molecular response and clinical outcome[J].Haematologica,2007,92:42-49.
[15]	VANDENBERGHE E,RUIZ DE ELVIRA C,LOBERIZA F R,et al.Outcome of autologous transplantation for mantle cell lymphoma:a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries[J].Br J Haematol,2003,120:793-800.
[16]	VOSE J,LOBERIZA F,BIERMAN P J,et al.Mantle cell lymphoma(MCL):Induction therapy with HyperCVAD/High-dose methotrexate and cytarabine(M-C)(+/-Rituximab)improves results of autologous stem cell transplant in first remission[J].J Clin Oncol,2006,24(suppl 18S):424s.
[17]	ROMAGUERA J E,FAYAD L,RODRIGUEZ M A,et al.High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine[J].J Clin Oncol,2005,23:7013-7023.
[18]	RITCHIE D S,SEYMOUR J F,GRIGG A P,et al.The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan,melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma[J].Ann Hematol,2007,86:101-105.
[19]	VANDENBERGHE E,RUIZ DE ELVIRA C,ISAACSON P,et al.Does transplantation improve outcome in mantle cell lymphoma(MCL)?A study from the EBMT[J].Blood,2000,96:482a.
[20]	SAVAGE K J.Aggressive peripheral T-cell lymphomas(specified and unspecified types)[J].Hematol Am Soc Hematol Educ Program,2005,267-277.
[21]	FAULKNER R D,CRADDOCK C,BYRNE J L,et al.BEAM-alemtuzumab reduced-intensity allogeneic stem cell transpl antation for lymphoproliferative diseases:GVHD,toxicity,and survival in 65 patients[J].Blood,2004,103:428-34.
[22]	KWONG Y L.Natural killer-cell malignancies:diagnosis and treatment[J].Leukemia,2005,19:2186-2194.
[23]	LI C C,TIEN H F,TANG J L,et al.Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma[J].Cancer,2004,100:366-375.
[24]	AU W Y,LIE A K,LIANG R,et al.Autologous stem cell transplantation for nasal NK/T-cell lymphoma:a progress report on its value[J].Ann Oncol,2003,14:1673-1676.
[25]	SUZUKI R,SUZUMIYA J,NAKAMURA S,et al.Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms[J].Bone Marrow Transplant,2006,37:425-431.
[26]	KIM H J,BANG S M,LEE J,et al.High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma:a retrospective comparison with non-transplantation cases[J].Bone Marrow Transplant,2006,37:819-824.
[27]	CORRADINI P,TARELLA C,ZALLIO F,et al.Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation[J].Leukemia,2006,20:1533-8153.
[28]	RODRIGUEZ J,CABALLERO M D,GUTIERREZ A,et al.High-dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy:the GEL-TAMO experience[J].Haematologica,2003;88:1372-1377.
[29]	KIM M K,KIM S,LEE S S,et al.High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma:complete response at transplant predicts survival[J].Ann Hematol,2007,86:435-442.
[30]	RODRIGUEZ J,CABALLERO M D,GUTIERREZ A,et al.High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma:the GEL-TAMO experience[J].Ann Oncol,2003,14:1768-1775.